Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 May 19;106(20):8374-9.
doi: 10.1073/pnas.0812675106. Epub 2009 May 5.

Clioquinol and pyrithione activate TRPA1 by increasing intracellular Zn2+

Affiliations

Clioquinol and pyrithione activate TRPA1 by increasing intracellular Zn2+

David A Andersson et al. Proc Natl Acad Sci U S A. .

Abstract

The antifungal and amoebicidal drug clioquinol (CQ) was withdrawn from the market when it was linked to an epidemic of subacute myelo-optico-neuropathy (SMON). Clioquinol exerts its anti-parasitic actions by acting as a Cu/Zn chelator and ionophore. Here we show that local injections of CQ produce mechanical hyperalgesia and cold hypersensitivity through a mechanism involving TRPA1 in mice. We also show that CQ activates TRPA1 in a Zn(2+)-dependent manner. Using a different Zn(2+)-ionophore, zinc pyrithione (ZnPy), we demonstrate that low, nanomolar concentrations of intracellular Zn(2+) ([Zn(2+)](i)) stimulate TRPA1. Direct application of Zn(2+) to the intracellular face of excised, inside-out patches activates TRPA1 with an EC(50) value of 7.5 +/- 1 nM. TRPA1 is expressed in a subpopulation of nociceptive dorsal root ganglion (DRG) neurons, where it acts as a sensory receptor for environmental irritants and oxidants. Using cultured DRG neurons from wild-type and TRPA1-deficient mice, we demonstrate that TRPA1 is the principal excitatory receptor for increased [Zn(2+)](i) in DRG neurons. In conclusion, we have discovered that TRPA1 acts a sensor of intracellular Zn(2+), and that Zn(2+) ionophores, such as CQ and ZnPy, activate TRPA1 by increasing [Zn(2+)](i). We also demonstrate that CQ-evoked mechanical hyperalgesia and cold allodynia require TRPA1 in vivo.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1.
Fig. 1.
TRPA1 is required for the acute nociceptive effects of CQ. Mice (trpa1+/+ and trpa1−/−) received intraplantar injections of CQ (2.5 nmoles in 25 μl) and were examined for mechanical hyperalgesia (A, paw withdrawal threshold, paw pressure), cold hypersensitivity (B, paw withdrawal latency) and tactile allodynia (C, paw withdrawal threshold, von Frey). TRPA1-deficient mice had significantly higher thresholds and longer latencies than wildtype mice before administration of CQ (time = 0) in all three tests. CQ markedly reduced the withdrawal thresholds (A and C) and latency (B) in the injected paw of wild-type mice (+/+). In contrast, clioquinol only produced tactile allodynia (C) in TRPA1-deficient mice (-/-) and had no effect in the paw pressure and cold withdrawal tests. (n = 6; †, P < 0.05; ††, P < 0.01; †††, P < 0.001 compared to trpa1+/+ before administration of CQ; *, P < 0.05; **, P < 0.01; ***, P < 0.001 compared to the contralateral paw).
Fig. 2.
Fig. 2.
CQ is a TRPA1 agonist. CQ (10 μM) activates TRPA1 currents in CHO cells in Ca2+-containing (A) and Ca2+-free external solutions (B). (C) Pretreatment of the cells with a membrane permeable (TPEN), but not an impermeable (DTPA) Zn2+ chelator, significantly reduced the amplitudes of CQ-induced currents (**, P < 0.01).
Fig. 3.
Fig. 3.
Zn2+ is a potent TRPA1 activator. In the whole-cell configuration ZnPy stimulates TRPA1 with an EC50 of 2.4 μM (A and B; whole cell, −60 mV). DTPA, a membrane impermeable Zn2+ chelator completely prevents the ZnPy-induced activation of TRPA1 (C and D; n = 4–8). ZnPy (10 μM) rapidly evokes TRPA1 currents in cell attached patches (E). The patch pipette contained 5 mM BAPTA to remove any Zn2+ and Ca2+ from the extracellular side of the membrane. (F) FluoZin-3 measurements of [Zn2+]i in untransfected CHO cells exposed to different concentrations of ZnPy for 2 min. (G) Concentration dependence of ZnPy-evoked Na+ influx (measured with SBFI) in untransfected CHO cells and cells expressing mouse or human TRPA1.
Fig. 4.
Fig. 4.
TRPA1 is activated by intracellular Zn2+. Application of Zn2+ to the intracellular face of excised patches concentration-dependently stimulates TRPA1. (A) No or very little TRPA1 channel activity was seen in response to 1 nM Zn2+, whereas 14 nM Zn2+ (B) rapidly evoked a marked increase in channel activity (−60 mV). (C) Concentration dependence of the agonist activity of Zn2+ in inside-out patches (EC50 = 7.5 ± 1 nM). Each data point is the mean ± SEM. NPo during a 60-s local Zn2+-application of n = 4–6 patches. Only patches without significant channel activity before application of Zn2+ were analyzed.
Fig. 5.
Fig. 5.
TRPA1 is necessary for ZnPy evoked [Ca2+]i responses in DRG neurons. (A) ZnPy (1 μM) rapidly evokes a Ca2+-response in DRG neurons expressing TRPA1, whereas Zn2+ (10 μM) was unable to evoke responses. A brief pulse of ZnPy produced rapid elevations in [Ca2+]i in 40% (76 of 188) of capsaicin-sensitive DRG neurons cultured from TRPA1+/+ mice (B), but only evoked a small [Ca2+]i increase in 1% (3 of 201) of capsaicin-sensitive neurons from TRPA1−/− mice (C).

References

    1. Konagaya M, et al. Clinical analysis of longstanding subacute myelo-optico-neuropathy: Sequelae of clioquinol at 32 years after its ban. J Neurol Sci. 2004;218:85–90. - PubMed
    1. Kumazawa T, Mizumura K. Abnormal activity of polymodal receptors induced by clioquinol (5-chloro-7-iodo-8-hydroxyquinoline) Brain Res. 1984;310:185–188. - PubMed
    1. Arbiser JL, et al. Clioquinol-zinc chelate: A candidate causative agent of subacute myelo-optic neuropathy. Mol Med. 1998;4:665–670. - PMC - PubMed
    1. venisti-Zarom L, Chen J, Regan RF. The oxidative neurotoxicity of clioquinol. Neuropharmacology. 2005;49:687–694. - PubMed
    1. Dillaha CJ, Lorincz AL, Avik OR. Acrodermatitis enteropathica; review of the literature and report of a case successfully treated with diodoquin. J Am Med Assoc. 1953;152:509–512. - PubMed

Publication types